Commentary

Infected with COVID-19: One psychiatrist’s story

Author and Disclosure Information

 

Anne was ahead of the curve and advocated hard for both treatments. At the same time, my OSUMC physicians were considering other options for me. They were checking on my inflammatory status by following my levels of C-reactive protein (CRP) and interleukin-6 (IL-6). On Days 2 and 3, my CRP level was 64 mg/L and my IL-6 level was 32 pg/mL (neither should be higher than 1).

While I don’t recall much before being on the ventilator, I do recall my alarm at seeing my CRP/IL-6 levels go up in real time on alerts from “My Chart” (my CRP/IL-6 levels were 149/123 within 4 days of admission, and reached a high of about 250/190 as I entered the ICU). I knew what those numbers meant. It was surreal; like watching myself die off in the distance, emotionally disconnected from the whole scene.

The decision to give steroids was relatively easy, and I was started on dexamethasone, a very inexpensive steroid, on Day 7 (ICU Day 2). The decision of which “antiinflammatory” to give was more difficult, as OSUMC had over 40 treatment protocols for COVID. Anne suggested 2 drugs based on recommendations from our physician friends—tocilizumab and acalabrutinib— both were on the market for other conditions and very expensive. The first is an IL-6 antagonist, while the second shuts down cytokine production in B cells, an effect also observed in lung tissue. While tocilizumab was not included in any of the OSUMC COVID protocols, acalabrutinib was, and I started on that medication on Day 8 (ICU Day 3).

Anne: My experience being the advocate was different than the first time 10 years before. That time, Emil had a community-acquired pneumonia, with which our doctors had much experience. This time, I was more active because no one had much information about how to deal with COVID and, thus, there was no standard of care. In fact, Emil was only the second patient to receive acalabrutinib at OSUMC; later, we found out that that patient did well.

Emil: The “anti-inflammatory” strategy worked. Within 5 days of starting the 2 drugs, my CRP and IL-6 levels were down to 10 and 5, respectively; a reduction of >95%. As these levels dropped, so did my oxygen requirements.

Continue to: Anne's reply

Pages

Recommended Reading

Consensus guidelines address inpatient diabetes technology
Covid ICYMI
COVID frontline physicians afraid to seek mental health care
Covid ICYMI
Chinese American families suffer discrimination related to COVID-19
Covid ICYMI
Video capsule endoscopy shows superiority, may reduce coronavirus exposure
Covid ICYMI
More mask wearing could save 130,000 US lives by end of February
Covid ICYMI
COVID-19 diagnosed on CTA scan in stroke patients
Covid ICYMI
Skin symptoms common in COVID-19 ‘long-haulers’
Covid ICYMI
Two COVID-19 outpatient antibody drugs show encouraging results
Covid ICYMI
COVID and med ed cost: Are future docs paying more for less?
Covid ICYMI
Hospitalists are natural leaders in the COVID-19 battle
Covid ICYMI